LEADER 04418nam  22005775  450 
001 9910373946603321
005 20200704070437.0
010   $a3-030-27492-6
024 7 $a10.1007/978-3-030-27492-4
035   $a(CKB)4940000000160295
035   $a(MiAaPQ)EBC6002547
035   $a(DE-He213)978-3-030-27492-4
035   $a(PPN)242848079
035   $a(EXLCZ)994940000000160295
100   $a20200101d2020      u|             0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$a Extemporaneous Ophthalmic Preparations$b[electronic resource] /$fby Eman Ali Saeed Alghamdi, Abdulmalik Yahya Al Qahtani, Mazen M. Sinjab, Khalid Mohammed Alyahya
205   $a1st ed. 2020.
210  1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2020.
215   $a1 online resource (116 pages)
311   $a3-030-27491-8 
320   $aIncludes bibliographical references and index.
327   $aSection 1: Introduction to Extemporaneous Ophthalmic Preparations -- Chapter 1 Ocular Pharmacokinetics -- Chapter 2 Factors Affecting Bioavailability and Efficacy of Topical Eye Preparations -- Chapter 3 Ideal Characteristics of Ophthalmic Drug Delivery System -- Chapter 4 Inert Substances Used in the Proration of Ophthalmic Products -- Chapter 5 Preservatives Used in Ophthalmic Preparations -- Section 2: Extemporaneous Topical Ophthalmic Formulations -- Chapter 6 Topical Ophthalmic Drug Forms -- Chapter 7 Extemporaneous Compounding of Ophthalmic Products -- Chapter 8 American Society of Hospital Pharmacists (ASHP) Guidelines on Pharmacy-Prepared Ophthalmic Products -- Chapter 9 Formulations of Extemporaneous Topical Ophthalmic Preparations -- Chapter 10 Extemporaneous Ophthalmic Preparations in Ocular Oncology -- Section 3: Extemporaneous Intraocular Injections. Chapter 11 Extemporaneous Intravitreal Injections -- Chapter 12 Extemporaneous Intracameral Injections -- Chapter 13 Formulations of Extemporaneous Intraocular Injections -- Section 4: Extemporaneous Sub Conjunctival Injections -- Chapter 14 Equipment -- Chapter 15 Steps for subconjunctival injections -- Chapter 16 Formulations of Extemporaneous Intraocular Injections.
330   $aThis book provides a list of concise extemporaneous ophthalmic preparations, and standardizes the formulation of the products by suggesting specific strength, route of administration, appropriate vehicle, and method of preparation. Pharmaceutical industries have greatly expanded their share of ophthalmic drugs in recent years. However, physicians and pharmacists are frequently called to prepare sterile products intended for ophthalmic use due to lack of availability of licensed drugs in the market. This book contains the most appropriate formulation of each medication based on published and documented stability data. Extemporaneous Ophthalmic Preparations is the first book of its kind, making it a unique and valuable companion for many physicians and pharmacy practitioners who are frequently engaged in the compounding of sterile ophthalmic preparation.
606   $aOphthalmology
606   $aPharmacy
606   $aPharmacology
606   $aOphthalmology$3https://scigraph.springernature.com/ontologies/product-market-codes/H44004
606   $aPharmacy$3https://scigraph.springernature.com/ontologies/product-market-codes/F00008
606   $aDrug Safety and Pharmacovigilance$3https://scigraph.springernature.com/ontologies/product-market-codes/H69010
606   $aPharmacology/Toxicology$3https://scigraph.springernature.com/ontologies/product-market-codes/B21007
615  0$aOphthalmology.
615  0$aPharmacy.
615  0$aPharmacology.
615 14$aOphthalmology.
615 24$aPharmacy.
615 24$aDrug Safety and Pharmacovigilance.
615 24$aPharmacology/Toxicology.
676   $a617.7061
700   $aAlghamdi$b Eman Ali Saeed$4aut$4http://id.loc.gov/vocabulary/relators/aut$0995898
702   $aAl Qahtani$b Abdulmalik Yahya$4aut$4http://id.loc.gov/vocabulary/relators/aut
702   $aSinjab$b Mazen M$4aut$4http://id.loc.gov/vocabulary/relators/aut
702   $aAlyahya$b Khalid Mohammed$4aut$4http://id.loc.gov/vocabulary/relators/aut
906   $aBOOK
912   $a9910373946603321
996   $aExtemporaneous Ophthalmic Preparations$92282126
997   $aUNINA